Shanghai MicroPort Medical (Group) Co., Ltd.

MicroPort® originated from Shanghai MicroPort Medical (Group) Co., Ltd., established in 1998. It is an innovative high-end medical device group, headquartered in Zhangjiang Science City, Shanghai, China. Its business covers twelve major business clusters: cardiovascular and structural heart disease, electrophysiology and cardiac rhythm management systems, bone and soft tissue repair technology, aortic and peripheral vascular diseases, cerebrovascular and neuromodulation science, surgical critical care and robotics, endocrine management and assisted reproduction, urological, gynecological, gastrointestinal, respiratory, and digestive diseases, otorhinolaryngological, ophthalmic, and body contouring aesthetics, in vitro diagnostics and internal and external imaging, solid tumor treatment technology, and insomnia, depression, and rehabilitation medicine. MicroPort® has established major production (R&D) bases in Shanghai, Suzhou, Jiaxing, and Shenzhen in China; Memphis in the United States; near Paris in France; near Milan in Italy; and the Dominican Republic, forming a globalized R&D, production, marketing, and service network. "Helping billions of people on Earth stride healthily beyond the 115-year life line" is the original aspiration and belief of MicroPort Medical Science Company. We welcome talents with "specialization, precision, uniqueness, and niche expertise" from all fields to join MicroPort, regardless of race, gender, background, or age, to strive together for this grand goal!